Ann: Preliminary Final Report-MMJ.AX, page-40

Agreed I think creso is worth keeping an eye on and certainly sounds as though it's developed from an experienced team, they have little differentiators to MMJ or MXC.

They have products which haven't been trialed or tested (MMJ and MXC have clinical trials into PLT101 And Derm products respectively)

Thanks for alerting me to them though I think after initial float on asx they will probably waiver down and they offer a good proposition for veterinary medicine which isn't being explored elsewhere (as far as I'm aware). Benefit is its probably more ethically sound to trial and cats and dogs with cancer than humans.

This article is a nice summary likely paid for but nice summary regardless.
http://finfeed.com/biotech/cph/medical-marijuana-company-creso-pharma-to-list-on-asx/20160803/

I agree with ambiguity. If you want to punt put a small amount in it otherwise watch and wait until they derisk themselves like MMJ or MXC